SK Life Science, Inc., the U.S. subsidiary of SK Biopharmaceuticals, is an innovative global pharmaceutical company focused on the research, development and treatment of central nervous system (CNS) disorders. The company has a pipeline of eight compounds in development for CNS disorders. For more information about SK life science, please visit us at, sklifescienceinc.com .
In 2020, SK life science received FDA approval for XCOPRI® (cenobamate tablets) CV.
For more information about XCOPRI®, please visit xcopri.com .
CONNECT WITH SK LIFE SCIENCE, INC.
Latest Sponsored Posts
Fighting for the Possibility of Zero Seizures
XCOPRI® patient Koral knows the challenges of living with epilepsy and the significance of potentially living with zero seizures.
Meet Natalie: STEPS Toward Zero Champion
STEPS Toward Zero is a movement developed by SK life science, featuring epilepsy advocate Natalie Beavers founder of Angels of Epilepsy.
My Continued Journey Toward Seizure Freedom
Mary Kate shares her personal experience with XCOPRI®: “I experienced fewer seizures. I went from having multiple seizures a day to having only a handful in a three-month period.”